Cannabis research
Cannabis research · page 2
- Opinion
Trump Just Put Cannabinoids Back in the Spotlight — Science Might Finally Catch Up
This opinion piece was written by Calvin Rasode, Vice President, Marketing, Brains Bioceutical When Donald Trump tweets, the world pays attention.
- Pharmaceutical
Standard Seed AI’s Platform Could Rewrite the Future of Cannabis Drug Discovery
At its core, Standard Seed AI’s technology has the power to scientifically validate the entourage effect, streamline drug discovery, and drastically reduce the time and cost of bringing cannabis-based medicines to market.
- Uncategorized
Cannabis Research Woefully Undersupported by State Sales Taxes, Says New Report
Cannabis-related scientific research is woefully undersupported in the US, with less than half of the states which have legalized cannabis in some form offering provisions for research.
- Uncategorized
DOJ Ruling on Judge Protections Could Accelerate Cannabis Research Lawsuit Against DEA
The US Department of Justice (DOJ) has determined that protections preventing the removal of Administrative Law Judges (ALJs) are unconstitutional and will no longer defend them in court, a move that could have significant implications for cannabis research.
- Events
Cannabis Advocacy Groups to Descend on Capital to Push for Legalization as Cannabis Research Funding Slashed
The largest bipartisan coalition of cannabis advocacy, industry, and grassroots organizations, is set to descend on the US capital for a week of action to push the Trump administration to legalize cannabis.
- Medical
UK Red Tape Is Forcing Cannabis Investment Overseas
A cannabinoid drug company has opted to undertake its trials in America due to the complexities of the UK’s licensing regime.
- Uncategorized
Canadian Government Could Face Class Action Lawsuit Over Cannabis Legalisation
The Canadian Federal government’s failure to facilitate research into the potential health issues associated with cannabis consumption.
- Companies
Apollon Formularies and Global Hemp Group sign Letter of Intent
UK-based Apollon Formularies and Global Hemp Group (GHG) have signed a Letter of Intent GHG will acquire the exclusive perpetual license for North America to certain Apollon Intellectual Property and proprietary technology.
- CBD Market
UK company granted ethics approval for CBD trial
The company has received Ethics Approval from Bellberry Human Research Ethics Committee in Australia.
- Pharmaceutical
Clinical trial application submitted to MHRA for cannabinoid medicine
The application has been submitted in preparation for a review.
- Uncategorized
“World’s largest” cannabis site to open in Uganda
The site will be opened by UK cannabis company Eden Pharma.
- Data & Analysis
Cellular Goods white paper explores cannabinoids for skincare
The paper explores what Cellular Goods refers to as the ‘5 A’s of cannabinoid skincare’.
